Press release
Global Epilepsy Monitoring Device Market Growing at a CAGR of 8.83% to Reach USD 1272.2 Million By 2030 | Infinium Global Research
Infinium Global Research's recent report illuminates the expanding landscape of the Epilepsy Monitoring Device Market, offering an in-depth analysis of segments, sub-segments, and regional dynamics shaping this burgeoning industry. The comprehensive study delves into the impact of drivers, restraints, and macro indicators on both global and regional fronts, presenting a compelling overview of trends, forecasts, and dollar values. The global epilepsy monitoring device market was valued at USD 661.6 Million in 2022 and is expected to reach USD 1272.2 Million by 2030 and grow at a CAGR of 8.83% over the forecast period.To Know More Request a Sample of this Report: https://www.infiniumglobalresearch.com/reports/sample-request/18084
The global epilepsy monitoring device market is poised to witness a significant growth trajectory, projected to surge at a noteworthy Compound Annual Growth Rate (CAGR) of 8.83% between 2023 and 2030 in terms of value. This upsurge is attributed to the critical role played by epilepsy monitoring devices in diagnosing brain abnormalities. Real-time monitoring and seizure detection have become increasingly crucial in recent years.
According to the Centers for Disease Control and Prevention, approximately 3.4 million Americans, including 470,000 children, live with epilepsy. Alarmingly, about 35% do not respond to medication, necessitating advanced monitoring solutions. The market has responded with innovative devices like mHealth wearables such as the SmartWatch Inspyre™ for the Apple Watch, designed to track epileptic seizures and alert care teams, significantly enhancing patient safety.
The prevalence of epilepsy, affecting around 50 million individuals globally, poses a significant burden in terms of disability, stigma, mortality, comorbidities, and costs. This burden drives the escalating demand for epilepsy monitoring devices. Furthermore, increased awareness about epilepsy and the surge in device usage propel market growth. However, diagnostic challenges remain a hurdle due to the diversity in seizure types and appearances, complicating accurate diagnosis.
Geographically, North America holds a dominant position in the epilepsy monitoring device market, attributed to advanced healthcare facilities and a robust healthcare infrastructure. With an estimated average incidence of 150,000 cases annually in the U.S., the growing prevalence further fuels market growth in this region. Conversely, Asia Pacific emerges as the fastest-growing region due to its large population with epilepsy prevalence.
Key players in the global epilepsy monitoring device market include Medtronic plc, Koninklijke Philips N.V., Natus Medical Incorporated, Nihon Kohden Corporation, LivaNova, PLC, St. Jude Medical, Inc., Empatica Inc., and Boston Scientific Corporation.
Epilepsy, classified as a common neurological disease globally, affects around 50 million individuals. The International League Against Epilepsy (ILAE) suggests that genetic factors contribute to approximately 30% of epilepsy cases, with idiopathic epilepsy being prevalent in cases where no cause can be identified.
The absence of a cure for epilepsy promotes innovation among monitoring device manufacturers. These devices serve as vital tools for healthcare professionals in quantifying seizures, aiding in more reliable treatment decisions. Advanced monitoring devices equipped with video capabilities offer improved seizure visualization, particularly beneficial for individuals with infrequent or varied seizure types, and those lacking access to specialist care.
Despite technological advancements, challenges persist in accurately diagnosing epilepsy due to limited opportunities to observe seizures and diverse seizure appearances. The continuous quest for more advanced, continuous, and accurate monitoring options by healthcare professionals drives the demand for enhanced monitoring devices.
The U.S. Food and Drug Administration's approval of a mHealth wearable capable of detecting epileptic seizures and immediately alerting care teams underscores the ongoing technological advancements revolutionizing the field. These innovations, including bracelets, mattress devices, and smartwatches, enable real-time seizure recording by caregivers and family members.
Enquire Here Get Customization & Check the Discount for the Report @ https://www.infiniumglobalresearch.com/reports/customization/18084
Table of Content
Chapter 1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
Chapter 2. Executive Summary
2.1. Epilepsy Monitoring Device Market Highlights
2.2. Epilepsy Monitoring Device Market Projection
2.3. Epilepsy Monitoring Device Market Regional Highlights
Chapter 3. Global Epilepsy Monitoring Device Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.4.1. IGR-Growth Matrix Analysis by Product
3.4.2. IGR-Growth Matrix Analysis by End User
3.4.3. IGR-Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Epilepsy Monitoring Device Market
Chapter 4. Epilepsy Monitoring Device Market Macro Indicator Analysis
Chapter 5. Global Epilepsy Monitoring Device Market by Product
5.1. Conventional Devices
5.2. Wearable Devices
Chapter 6. Global Epilepsy Monitoring Device Market by End User
6.1. Clinics
6.2. Hospitals
6.3. Home Care Settings
6.4. Other End Users
Chapter 7. Global Epilepsy Monitoring Device Market by Region 2023-2030
7.1. North America
7.1.1. North America Epilepsy Monitoring Device Market by Product
7.1.2. North America Epilepsy Monitoring Device Market by End User
7.1.3. North America Epilepsy Monitoring Device Market by Country
7.2. Europe
7.2.1. Europe Epilepsy Monitoring Device Market by Product
7.2.2. Europe Epilepsy Monitoring Device Market by End User
7.2.3. Europe Epilepsy Monitoring Device Market by Country
7.3. Asia-Pacific
7.3.1. Asia-Pacific Epilepsy Monitoring Device Market by Product
7.3.2. Asia-Pacific Epilepsy Monitoring Device Market by End User
7.3.3. Asia-Pacific Epilepsy Monitoring Device Market by Country
7.4. RoW
7.4.1. RoW Epilepsy Monitoring Device Market by Product
7.4.2. RoW Epilepsy Monitoring Device Market by End User
7.4.3. RoW Epilepsy Monitoring Device Market by Sub-region
Chapter 8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Epilepsy Monitoring Device Market
8.2. Companies Profiles
8.2.1. Medtronic plc
8.2.2. Koninklijke Philips N.V.
8.2.3. Natus Medical Incorporated
8.2.4. Nihon Kohden Corporation
8.2.5. LivaNova, PLC
8.2.6. St. Jude Medical, Inc.
8.2.7. Empatica Inc.
8.2.8. Boston Scientific Corporation
Chapter 9. Appendix
9.1. Primary Research Findings and Questionnaire
More Insights on this report, Speak to Our Analyst: https://www.infiniumglobalresearch.com/reports/enquiry/18084
Reasons to Buy this Report:
=> Comprehensive analysis of global as well as regional markets of Epilepsy Monitoring Device.
=> Complete coverage of all the product types and application segments to analyze the trends, developments, and forecast of market size up to 2030.
=> Comprehensive analysis of the companies operating in this market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
=> Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand, and/or diversify.
2nd Floor, Ganadish Empire, Rahatani Chowk, Pimple Saudagar, Pimpri-Chinchwad, Maharashtra 411027
About Infinium Global Research:
Infinium Global Research is a business consulting and market research firm; a group of experts that caters to fulfilling business and market research needs of leading companies in various industry verticals and business segments. The company also serves government bodies, institutes, and non-profit/non-government organizations to meet their knowledge and information needs.
Through our information services and solutions, we assist our clients to improve their performance and assess the market conditions to achieve their organizational goals. Our team of experts and analysts are engaged in continuously monitoring and assessing the market conditions to provide knowledge support to our clients. To help our clients and to stay updated with the advances and inventions in technology, business processes, regulations, and the environment, Infinium often conducts regular meets with industry experts and opinion leaders. Our key opinion leaders are involved in monitoring and assessing the progress in the business environment, so as to offer the best opinion to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Epilepsy Monitoring Device Market Growing at a CAGR of 8.83% to Reach USD 1272.2 Million By 2030 | Infinium Global Research here
News-ID: 3295787 • Views: …
More Releases from Infinium Global Research LLP
Saudi Arabia Healthcare Cybersecurity Market is Expected to Reach USD 1650 Milli …
The Saudi Arabia healthcare cybersecurity market has entered a phase of accelerated growth, driven by the country's ongoing digital transformation and the rapid adoption of advanced healthcare IT platforms. Valued at USD 540 million in 2023, the market is projected to reach USD 1,650 million by 2032, expanding at a CAGR of 15% during 2024-2032. This growth is fueled by the Kingdom's National e-Health Strategy, rising cyberthreats targeting healthcare systems,…
Global Aviation Fuel Market Outlook 2024-2032: Growth from USD 289.34 Billion to …
The aviation fuel market has expanded steadily in recent years, driven by rising global air traffic, economic improvements, and the rapid expansion of commercial and cargo aviation networks. The market was valued at USD 289.34 billion in 2023 and is projected to reach USD 437.34 billion by 2032, reflecting stable expansion supported by increasing aircraft operations, modernization of fleets, and the growing need for reliable fuel logistics. Key growth drivers…
United States Beauty and Wellness Market is Expected to Reach USD 143.27 Million …
The United States beauty and wellness market continues to evolve rapidly, shaped by shifting consumer priorities, rising disposable incomes, digital-first retail strategies, and the strong influence of self-care culture. With a valuation of USD 97 billion in 2023, the market is firmly positioned as one of the world's largest and most dynamic consumer-driven sectors. Increased awareness of holistic wellbeing, demand for clean beauty solutions, and adoption of premium skincare and…
United States Pharmerging Market is Expected to Reach USD 1172.82 Billion in 203 …
The United States pharmerging market has emerged as one of the fastest-growing components of the broader healthcare and pharmaceutical ecosystem, driven by rapid advancements in drug manufacturing, rising healthcare expenditure, and a surge in lifestyle-related diseases. Valued at USD 540 billion in 2023, the market is projected to reach USD 1172.82 billion by 2032, expanding at a CAGR of 9% during 2024-2032. This growth reflects the country's robust pharmaceutical infrastructure…
More Releases for Epilepsy
Adult mitochondrial epilepsy presentation
Mitochondrial epilepsy is a rare but severe neurological condition caused by genetic mutations that impair mitochondrial function, disrupting cellular energy production in the brain. Patients often present with seizures, developmental delays, and neurodegeneration. It is closely associated with broader mitochondrial diseases such as MELAS (Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes) and Leigh syndrome.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72869
Due to its rarity and complexity, treatment options…
Portable Epilepsy Monitoring Market in 2025
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Portable Epilepsy Monitoring Market- (By Product Type (Device Type (Chest Sensor, Watch Sensor, Monitors, Cameras, Mattresses and Pillows, and Others) and Service), By End User (Hospitals, Ambulatory Surgery Centres & Clinics, Neurology Centres, and Home Care Settings)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global…
Top 10 Epilepsy Companies Analysis (2024)
Epilepsy also known as seizure disorder, is a chronic noncommunicable disease that affects brain. Epilepsy affects people of all races, ethnic backgrounds, genders, and ages.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00016405/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Epilepsy Market are:
• Idexx Laboratories Inc.
• PBD Biotech Ltd
• Thermo Fisher Scientific Inc.
• Innovative Diagnostics SAS
• Neogen Corp
• Enfer Labs
• bioMerieux SA
• Ring Biotechnology Co Ltd
• Bionote Inc.
• Shenzhen Bioeasy Biotechnology Co Ltd.
Contact Us:
If you have any queries about this report or if…
Epilepsy Market: Trends, Opportunities, and Challenges
Epilepsy is a neurological disorder characterized by recurrent seizures, which are caused by abnormal electrical activity in the brain. This condition affects millions of people globally, making it one of the most common neurological disorders. As the global burden of epilepsy increases, the demand for effective treatments and solutions continues to grow. The epilepsy market is evolving rapidly, with advancements in medication, diagnostics, and therapeutic technologies. This guest post aims…
Epilepsy Device Market: for Epilepsy Devices Poised to Exceed $1 Billion by 2031 …
The global epilepsy devices market isx experiencing a remarkable surge, poised to exceed a valuation of $1.1 billion by 2031, as revealed by the latest market analysis. According to the report released by Allied Market Research, the market was valued at $675.23 million in 2021 and is projected to grow at a CAGR of 5.1% from 2022 to 2031.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲: https://www.alliedmarketresearch.com/request-sample/A14821
Epilepsy devices play…
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market - Breaking the Sei …
Newark, New Castle, USA: The "Epilepsy with Myoclonic-Atonic Seizures Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Epilepsy with Myoclonic - Atonic Seizures Therapeutics Market: https://www.growthplusreports.com/report/epilepsy-with-myoclonic-atonic-seizures-therapeutics-market/8029
This…
